Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Krystal Biotech, Inc.
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 26, 2026
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
May 25, 2026
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
May 24, 2026
Krystal Biotech to Present at Upcoming Scientific Conferences
May 24, 2026
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026
May 22, 2026